Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion type Assertion NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_head.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion description "[These results suggest that the ALK5-SMAD4 part of the TGFB signalling pathway is a major target for inactivation in pancreatic carcinomas, that the expression of TGFBR2, TGFBR3, and receptors involved in TGFB activation are maintained, and that alterations of components of the TGFB signalling pathway may be accompanied by a positive effect of TGFB on cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_provenance.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion evidence source_evidence_literature NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_provenance.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion SIO_000772 11408925 NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_provenance.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion wasDerivedFrom befree-20140225 NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_provenance.
- NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_assertion wasGeneratedBy ECO_0000203 NP444541.RAjj-bhZt-NXWBgaHSBr_H_0fJV5nuIQDUjyMgnrOdJpA130_provenance.